Cargando…
Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines
Purpose: We investigated the persistence of the vaccine-induced immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCWs) in Odisha who received a complete dose of either Covaxin or Covishield vaccine. Methods: This 24-week...
Autores principales: | Choudhary, Hari Ram, Parai, Debaprasad, Chandra Dash, Girish, Kshatri, Jaya Singh, Mishra, Narayan, Choudhary, Prasanta Kumar, Pattnaik, Dipti, Panigrahi, Kumudini, Behera, Susmita, Ranjan Sahoo, Nihar, Podder, Sreeparna, Mishra, Adyasha, Raghav, Sunil Kumar, Mishra, Sanjeeb Kumar, Pradhan, Subrat Kumar, Sahoo, Subrat Kumar, Pattnaik, Matrujyoti, Rout, Usha Kiran, Nanda, Rashmi Ranjan, Mondal, Nityananda, Kanungo, Srikanta, Palo, Subrata Kumar, Bhattacharya, Debdutta, Pati, Sanghamitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727751/ https://www.ncbi.nlm.nih.gov/pubmed/35004746 http://dx.doi.org/10.3389/fmed.2021.778129 |
Ejemplares similares
-
Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection
por: Parai, Debaprasad, et al.
Publicado: (2021) -
Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study
por: Parai, Debaprasad, et al.
Publicado: (2022) -
Perception and determinants leading to antimicrobial (mis)use: A knowledge, attitude, and practices study in the rural communities of Odisha, India
por: Pattnaik, Matrujyoti, et al.
Publicado: (2023) -
Effectiveness of the BBV-152 and AZD1222 vaccines among adult patients hospitalized in tertiary hospitals in Odisha with symptomatic respiratory diseases: A test-negative case–control study
por: Bhattacharya, Debdutta, et al.
Publicado: (2023) -
IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)